bromfenac has been researched along with ketorolac tromethamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Jolas, T; Silliman, D; Waterbury, LD | 1 |
| Bond, W; Golben, MR; Sher, NA; Tauber, S; Trattler, WB; Voirin, TG | 1 |
| Bucci, FA; Waterbury, LD | 1 |
| Erdahl, WE; Gadd, ME; Graff, G; Kumar, J; Lal, N; Pfeiffer, DR; Yanni, JM | 1 |
| Chen, Y; Dong, Y; Wang, B; Xia, Y; Zhang, Y | 1 |
3 trial(s) available for bromfenac and ketorolac tromethamine
| Article | Year |
|---|---|
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Female; Humans; Ketorolac Tromethamine; Lasers, Excimer; Male; Myopia; Pain Measurement; Pain, Postoperative; Photophobia; Photorefractive Keratectomy; Treatment Outcome; Wound Healing | 2009 |
Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Cataract Extraction; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac Tromethamine; Male; Middle Aged; Ophthalmic Solutions; Preoperative Care | 2009 |
[Efficacy observation of 0.1% bromfenac sodium eye drops on relieving the post-LASEK irritative symptoms].
Topics: Adult; Benzophenones; Bromobenzenes; Cornea; Female; Humans; Keratectomy, Subepithelial, Laser-Assisted; Ketorolac Tromethamine; Male; Ophthalmic Solutions; Visual Acuity; Wound Healing | 2015 |
5 other study(ies) available for bromfenac and ketorolac tromethamine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Activation; Eye Diseases; Humans; Inflammation; Ketorolac Tromethamine; Rabbits; Recombinant Proteins | 2006 |
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Celecoxib; Diclofenac; Ketorolac Tromethamine; Male; Membrane Potentials; Mitochondria, Liver; Molecular Structure; Oxidative Stress; Permeability; Phenylacetates; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature; Time Factors | 2009 |